Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Brown, H. Rupani, C. Barber, S. Elliot, K. Gove, L. Lau, L. Hewitt, E. Ray, E. Aitken, S. Kerley, R. Kurukulaaratchy, C. Grainge, R. Djukanovic, A. Chauhan, P. Howarth (Portsmouth, Southampton, United Kingdom). Dissociation between clinical trial inclusion and exclusion criteria for trials in severe asthma and the reality of the patient population. Eur Respir J 2014; 44: Suppl. 58, 3326

Member's Comments

No comment yet.

Related content which might interest you: What are common COPD symptoms in a real-life setting? The German DACCORD registry Source: International Congress 2014 – COPD markers Year: 2014 P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients Source: International Congress 2016 – Asthma management Year: 2016 Pharmacokinetics of tiotropium in asthma patients from three paediatric clinical trials Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies Year: 2016 A randomized phase 3 study of the efficacy and safety of reslizumab in subjects with asthma with elevated eosinophils Source: International Congress 2014 – Clinical trials of drugs and biomarkers for respiratory diseases Year: 2014 Efficacy of omalizumab in Polish real-world patients Source: International Congress 2016 – Asthma management Year: 2016 A randomized phase 3 study of reslizumab efficacy in relation to blood eosinophil levels in patients with moderate to severe asthma Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases Year: 2014 Experience with omalizumab in patients with moderate and severe asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 LATE-BREAKING ABSTRACT: Effectiveness of individualized self management support for children with asthma in Dutch outpatient clinics, preliminary results of a randomized controlled trial. Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Clinical profile and treatment of elderly patients hospitalized for acute exacerbation of asthma . A comparative study Source: International Congress 2014 – Asthma: clinical problems Year: 2014 International perspectives on severe asthma: Current and future challenges in patient care Source: International Congress 2016 – Asthma points to ponder Year: 2016 Distribution and outcomes of the new Spanish phenotype-based guideline for COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium Source: International Congress 2014 – Novel targets and drugs for asthma and COPD Year: 2014 Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Ketamine versus aminophylline for status asthmatic in children: A randomized, controlled trial Source: International Congress 2014 – Lung disease in neonates and beyond Year: 2014 A national database study of the effectiveness of switching real-life asthma patients to fostair Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Safety and tolerability of acute dosing of beta-blockers in asthma Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Clinical trials for elderly patients with multiple diseases (CHROMED): A pilot study Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Analysis of comorbidities and treatment patterns by GOLD 2013 criteria: Pooled data from Phase III aclidinium bromide studies Source: International Congress 2014 – Asthma and COPD management Year: 2014 Abediterol in stable asthma:efficacy, safety and tolerability results from a Phase II, randomised, crossover study Source: International Congress 2014 – Asthma and COPD management Year: 2014 Clinical, functional and laboratory assessment of treatment efficacy in COPD patients Source: International Congress 2014 – Predictors Year: 2014